权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

The role of ZAK in Shiga toxin/ricin-induced inflammation

ZAK 在志贺毒素/蓖麻毒素诱导的炎症中的作用

基本信息

批准号：
7992139
负责人：
CHELESTE M THORPE
金额：
$ 23.85万
依托单位：
TUFTS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-07-01 至 2012-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7992139
关键词：
Adenine Adverse effects Affinity Chromatography Animal Model Anisomycin Apoptosis Area Autoantigens Bacillus stearothermophilus Binding Blood Vessels Breathing C2H2 Zinc Finger CCL2 gene Cartoons Categories Cell Cycle Cell Cycle Arrest Cell Cycle Progression Cell Death Cell Nucleus Cells Cleaved cell Colitis Collaborations Complex Cysteine Cytoplasm Cytosol DNA Binding Data Depurination Development Differentiation and Growth Disease Dominant-Negative Mutation Effector Cell Elderly Elongation Factor Endocytosis Endoplasmic Reticulum Epidermal Growth Factor Epithelial Cells Escherichia coli EHEC Eukaryota Event Excision Family Fingers Funding Future Genes Goals Growth Guanine Nucleotide Dissociation Inhibitors Heart Hemolytic-Uremic Syndrome Histidine Histone H3 Homeostasis Human Human Genome Hybrids Hydrolysis Immune In Vitro Individual Infection Inflammation Inflammatory Inflammatory Response Injection of therapeutic agent Injury Intention Intestines Intoxication Investigation Ions Kidney Knockout Mice Knowledge Letters Leucine Zippers Life Link Lipids Lung MAP Kinase Gene MAP Kinase Kinase Kinase MAPK14 gene MAPK8 gene Mammalian Cell Maryland Mass Spectrum Analysis Mediating Messenger RNA Mining Mitogen-Activated Protein Kinase Inhibitor Modeling Morbidity - disease rate Mus N glycosidase N-terminal Oral Organ Paper Pathogenesis Pathway interactions Patients Pharmaceutical Preparations Phase Phosphorylation Phosphotransferases Placenta Play Pneumonia Poisoning Positioning Attribute Process Production Property Protein Biosynthesis Protein Kinase Protein Synthesis Inhibition Protein Synthesis Inhibitors Protein Tyrosine Kinase Proteins Proteome Publishing RNA RNA Splicing RNA, Ribosomal, 28S RNA-Binding Proteins Receptor Cell Recruitment Activity Relative (related person)Research Research Personnel Ribosomal Proteins Ribosomal RNA Ribosomes Ricin Role SAM Domain Screening procedure Shiga Toxin Signal Pathway Signal Transduction Signal Transduction Pathway Site Small Interfering RNA Specificity Sterility Stimulus Stress Structure Syndrome Tertiary Protein Structure Therapeutic Therapeutic Uses Tissues Toxin Transcriptional Activation Translational Regulation Translations U937 Cells Ultraviolet Rays Universities Up-Regulation Variant Virulence Factors Work Yeasts Zinc Zinc Fingers autoimmune arthritis base biological adaptation to stress cDNA Library chemokine cytokine cytotoxicity deoxynivalenol drug candidate endoplasmic reticulum stress holotoxins human FRAP1 protein hydroxy-aluminum polymer in vivo inhibitor/antagonist intestinal epithelium kidney cell macrophage member monocyte mortality new therapeutic target novel novel therapeutics overexpression polypeptide prevent public health relevance response rho scaffold stress activated protein kinase stress-activated protein kinase 1 stressor therapeutic development therapeutic target tissue/cell culture trafficking working group

项目摘要

DESCRIPTION (provided by applicant): Inflammatory responses are natural consequences of many infections and can be a key protective response. However, in some cases, inflammation can cause devastating effects on the host. Cases of inadvertent intoxication of humans with either Shiga toxins or ricin occur, with serious and sometimes fatal effects, thus they are considered potential bioterror agents. One effect of these toxins is to stimulate host inflammation that ultimately damages the host. There are no established treatments for the diseases resulting from intoxication. To fully understand the unique intoxication syndromes associated with these protein synthesis inhibitors, it is essential to determine which aspects of disease pathogenesis are due to protein synthesis inhibition per se, and which aspects result from the novel immune activating properties now associated with these toxins. Our overall goal is to investigate critical host proteins activated by Shiga toxins/ricin that result in host-damaging inflammation. These host proteins would be potential therapeutic targets to prevent or treat Shiga toxin/ricin-associated diseases. We are the first group to identify a MAP3Kinase (called 'ZAK') that is associated with the proinflammatory signaling cascade initiated by these toxins. Our overall hypothesis is that Shiga toxin/ricin-induced ZAK activation contributes to overall host morbidity/mortality by causing host-damaging inflammation, and that ZAK may be a potential therapeutic target. To the best of our knowledge, we are the only group working on development of therapeutics for Shiga toxin/ricin-induced inflammation by targeting the MAP3Kinase(s) involved in the proinflammatory signaling cascade. In this proposal, we will create a murine line with a targeted deletion in ZAK, for use in Shiga toxin/ricin challenge models in which the mechanisms underlying immune-mediated damage can be studied. We will initiate studies to determine ZAK localization in cells under basal or intoxicated conditions. We will identify potential ZAK-interacting molecules using several complementary approaches, and evaluate the interaction(s) between ZAK and its binding partners. These molecules may be new therapeutic targets. PUBLIC HEALTH RELEVANCE: Inadvertent intoxication of humans with either Shiga toxins or ricin can cause serious and sometimes fatal effects. As a result, they are considered potential bioterror agents. There are no specific treatments for diseases caused these agents, so understanding how these toxins harm host cells is critical to understanding how to prevent illnesses that occur following inadvertent or intentional exposure.

描述(申请人提供)：炎症反应是许多感染的自然后果，可以是一种关键的保护性反应。然而，在某些情况下，炎症可能会对宿主造成毁灭性的影响。人类不慎中毒志贺毒素或蓖麻毒素的案例时有发生，影响严重，有时甚至致命，因此它们被认为是潜在的生物恐怖因子。这些毒素的一个作用是刺激宿主炎症，最终损害宿主。目前还没有针对醉酒引起的疾病的既定治疗方法。为了充分了解与这些蛋白质合成抑制剂相关的独特中毒综合征，有必要确定疾病发病机制的哪些方面是由于蛋白质合成抑制本身，以及哪些方面是由目前与这些毒素相关的新的免疫激活特性引起的。我们的总体目标是研究志贺毒素/蓖麻毒素激活的导致宿主破坏性炎症的关键宿主蛋白。这些宿主蛋白可能成为预防或治疗志贺毒素/蓖麻毒素相关疾病的潜在治疗靶点。我们是第一个发现MAP3Kinase(称为‘ZAK’)的小组，该酶与这些毒素启动的促炎信号级联反应有关。我们的总体假设是志贺毒素/蓖麻毒素诱导的ZAK激活通过引起宿主损伤性炎症而导致总体宿主发病率/死亡率，ZAK可能是一个潜在的治疗靶点。据我们所知，我们是唯一一个致力于通过靶向参与促炎信号级联反应的MAP3Kinase(S)来开发志贺毒素/蓖麻毒素引起的炎症的治疗方法的小组。在这项建议中，我们将创建一个ZAK基因定向缺失的小鼠株系，用于志贺毒素/蓖麻毒素攻击模型，在该模型中可以研究免疫介导的损伤机制。我们将启动研究，以确定Zak在基础或中毒条件下在细胞中的定位。我们将使用几种互补的方法识别潜在的ZAK相互作用分子，并评估ZAK与其结合伙伴之间的相互作用(S)。这些分子可能成为新的治疗靶点。与公共卫生相关：人类不慎中毒志贺毒素或蓖麻毒素可能会导致严重的、有时是致命的影响。因此，他们被认为是潜在的生物恐怖分子。目前还没有针对这些病原体引起的疾病的具体治疗方法，因此了解这些毒素是如何损害宿主细胞的，对于了解如何预防因无意或故意接触而发生的疾病至关重要。